Get informed when a big investor buys or sells
+ FollowOvervalued by 60.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $73.59 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.51 |
| Dividend yield | 1.45% |
| Earnings per Share | $1.15 |
| Beta | 0.81 |
| Outstanding Shares | 2,173,889,390 |
| P/E Ratio | 27.76 |
|---|---|
| PEG | -111.73 |
| Price to Sales | 3.74 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Merck KGaA is a venerable science and technology enterprise, headquartered in Darmstadt, Germany, where it was established in 1668. Operating as a subsidiary of E. Merck KG, the company organizes its diverse activities across three princ...